U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File Number
333-141327
(Check
One)
:
x
Form
10-K and Form 10-KSB
o
Form 20-F
o
Form 11-K
o
Form 10-Q
and Form 10-QSB
o
Form N-SAR
For Period Ended:
June 30, 2009
o
Transition
Report on Form 10-K
o
Transition
Report on Form 11-K
o
Transition
Report on Form 10-Q
o
Transition
Report on Form N-SAR
For the
Transition Period Ended:
Nothing in
this form shall be construed to imply that the Commission has verified any
information contained herein.
If the
notification relates to a portion of the filing checked above, identify the
Item(s) to which the notification relates:
Part I - Registrant Information
Full Name of Registrant
China
Dasheng Biotechnology Company
Former Name if Applicable _______________________________
Building
B 17
th
Floor, Century Plaza, Qingyang Road, Lanzhou, Gansu, PRC
Address of Principal Executive Office (
Street and Number
)
City, State and Zip Code
Part II - Rules 12b-25(b) and (c)
If the
subject report could not be filed without unreasonable effort or expense and
the registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
|
|
|
|
|
x
|
|
(a)The
reasons described in reasonable detail in Part III of this form could not be
eliminated without unreasonable effort or expense;
|
|
x
|
|
(b)The
subject annual report, semi-annual report, transition report on Form 10-K,
Form 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or before
the fifteenth calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the prescribed due
date; and
|
|
o
|
|
( c)The accountant’s statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
Part III - Narrative
State
below in reasonable detail the reasons why Form 10-K and Form 10-KSB, 20-F,
11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion thereof,
could not be filed within the prescribed time period. (Attach Extra
Sheets if Needed)
The
Company is unable to file its Annual Report on Form 10-K for the period ended
June 30, 2008 within the prescribed time period due to its difficulty in
completing and obtaining required financial and other information without
unreasonable effort and expense.
Part IV - Other Information
(1)
Name and telephone number of person to contact in regard to this
notification: Peter D Zhou 212-232-0058
(2)
Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer
is no, identify report(s). Yes
x
No
o
(3)
Is it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof?
Yes
o
No
x
|
China Dasheng Biotechnology Company
|
|
(Name of Registrant as Specified in Charter)
|
has caused
this notification to be signed on its behalf by the undersigned hereunto duly
authorized.
Date:
September 29, 2009
By:
/s/
Gang Chen
Name:
Gang Chen
Title:
Chief Executive Officer and President